AnGes Research Development from 2010 to 2026

AJW Stock  EUR 0.26  0.01  3.70%   
AnGes' Research Development is increasing over the last several years with slightly volatile swings. Research Development is estimated to finish at about 5.3 B this year. During the period from 2010 to 2026 AnGes Inc Research Development regressed destribution of quarterly values had coefficient of variationof  64.79 and r-value of  0.54. View All Fundamentals
 
Research Development  
First Reported
2017-03-31
Previous Quarter
971.5 M
Current Value
1.3 B
Quarterly Volatility
997.2 M
 
Covid
 
Interest Hikes
Check AnGes financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AnGes' main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 6.7 B or Total Revenue of 299.7 M, as well as many indicators such as . AnGes financial statements analysis is a perfect complement when working with AnGes Valuation or Volatility modules.
  
This module can also supplement various AnGes Technical models . Check out the analysis of AnGes Correlation against competitors.
The Research Development trend for AnGes Inc offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether AnGes is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest AnGes' Research Development Growth Pattern

Below is the plot of the Research Development of AnGes Inc over the last few years. It is AnGes' Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AnGes' overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

AnGes Research Development Regression Statistics

Arithmetic Mean4,220,630,394
Geometric Mean3,648,128,008
Coefficient Of Variation64.79
Mean Deviation1,917,961,498
Median3,532,000,000
Standard Deviation2,734,366,786
Sample Variance7476761.7T
Range8.6B
R-Value0.54
Mean Square Error5623527.9T
R-Squared0.29
Significance0.02
Slope294,039,102
Total Sum of Squares119628187.6T

AnGes Research Development History

20265.3 B
20254.4 B
20243.8 B
20236.2 B
202210.8 B
202110.8 B
20203.8 B

About AnGes Financial Statements

AnGes stakeholders use historical fundamental indicators, such as AnGes' Research Development, to determine how well the company is positioned to perform in the future. Although AnGes investors may analyze each financial statement separately, they are all interrelated. For example, changes in AnGes' assets and liabilities are reflected in the revenues and expenses on AnGes' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in AnGes Inc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Research Development4.4 B5.3 B

Currently Active Assets on Macroaxis

Other Information on Investing in AnGes Stock

AnGes financial ratios help investors to determine whether AnGes Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AnGes with respect to the benefits of owning AnGes security.